Hostname: page-component-586b7cd67f-t7fkt Total loading time: 0 Render date: 2024-11-24T21:50:15.822Z Has data issue: false hasContentIssue false
  • English
  • Français

Pharmacokinetic Aspects of Anxiolytic Drug Therapy

Published online by Cambridge University Press:  18 September 2015

David J. Greenblatt  and
Richard I. Shader
David J. Greenblatt*
Affiliation:
Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center Hospital
Richard I. Shader
Affiliation:
Division of Clinical Pharmacology, Departments of Psychiatry and Medicine, Tufts University School of Medicine and New England Medical Center Hospital
*
Division of Clinical Pharmacology, Box 1007, New England Medical Center Hospital, 171 Harrison Avenue, Boston, MA 02111
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Benzodiazepine derivatives are neuropharmacologically similar but may appear clinically distinct due to pharmacokinetic differences. The clinical effects of single doses depend mainly on rates of drug absorption and distribution, whereas drug accumulation is a major determinant of clinical action during multiple dosage. This paper outlines potential clinical implications of benzodiazepine pharmacokinetics.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 7 , Issue 3 , August 1980 , pp. 269 - 270
Copyright
Copyright © Canadian Neurological Sciences Federation 1980

References

REFERENCES

Breimer, D.D. (1979). Pharmacokinetics and metabolism of various benzodiazepines used as hypnotics. Br. J. Clin. Pharmacol., 8, 7s–13s.CrossRefGoogle ScholarPubMed
Curry, S.H., and Whelpton, R. (1979). Pharmacokinetics of closely related benzodiazepines. Br. J. Clin. Pharmacol., 8, 15s–21s.CrossRefGoogle ScholarPubMed
Greenblatt, D.J., and Shader, R.I. (1974). Benzodiazepines in Clinical Practice. New York, Raven Press.Google Scholar
Greenblatt, D.J., Allen, M.D., Maclaughlin, D.S., Harmatz, J.S., and Shader, R.I. (1978). Diazepam absorption: effect of antacids and food. Clin. Pharm. Ther., 24, 600–609.CrossRefGoogle ScholarPubMed
Greenblatt, D.J., and Shader, R.I. (1978). Pharmacokinetic understanding of antianxiety drug therapy. So. Med. J., 71 (Suppl 2), 2–9.CrossRefGoogle ScholarPubMed
Shader, R.I., and Greenblatt, D.J. (1977). Clinical implications of benzodiazepine pharmacokinetics. Am. J. Psychiat., 134, 652–656.Google ScholarPubMed
Greenblatt, D.J., Shader, R.I., Harmatz, J.S., Franke, K., and Kochweser, J. (1977). Absorption rate, blood concentrations, and early responses to oral chlordiazepoxide. Am. J. Psychiat., 134, 559–562.Google ScholarPubMed